Finally, sulphonamide 4 is a lead compound for the treatment of osteoarthritis via MMP-13 (matrix metalloproteinase 13) inhibition which exhibited an excellent selectivity profile and complete inhibition of collagenolysis in vitro [19]. The gene discussed is MMP13; the disease is osteoarthritis.